Navigation Links
Halozyme Therapeutics to Present at the Wedbush 2011 Global Healthcare Conference on August 17
Date:8/12/2011

SAN DIEGO, Aug. 12, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that management will be presenting at the Wedbush 2011 Life Sciences Conference in New York. The presentation is scheduled for Wednesday, August 17 at 9:10 a.m. EDT (6:10 a.m. PDT). To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the company's Web site at www.halozyme.com. A replay will be available for 90 days after the event.

(Logo:  http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

About Halozyme

Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the insulin, cancer, dermatology and drug delivery markets. The company's product portfolio is based primarily on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix. Halozyme's Enhanze(TM) technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. The company has key partnerships with Roche, Baxter, ViroPharma and Intrexon to apply Enhanze technology to therapeutic biologics including Herceptin®, MabThera®, immunoglobulin, Cinryze® and recombinant human alpha 1-antitrypsin. Halozyme's Ultrafast Insulin program combines its rHuPH20 enzyme with mealtime insulins, which may produce more rapid absorption, faster action, and improved glycemic control. The product candidates in Halozyme's pipeline target multiple areas of significant unmet
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Halozymes Ultrafast Insulin Demonstrates Reduced Variability of Insulin Absorption for Type 1 Diabetes Patients Using Insulin Pumps
2. Halozyme and Intrexon Announce Collaboration to Develop First Subcutaneous Recombinant Alpha 1-Antitrypsin Replacement Therapy
3. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
4. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
5. Halozyme Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference on May 12
6. Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6
7. Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
8. Halozyme Therapeutics to Host Fourth Quarter and 2010 Financial Results Conference Call on March 11
9. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
10. Halozyme Therapeutics Realigns Management
11. Halozymes rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , Mar. 26, 2015 Research and ... announced the addition of the "Urological ... report to their offering. This ... Catheters in Thousand Units and US$ Thousands ... (Hemodialysis Catheters, & Peritoneal Catheters), and Urinary ...
(Date:3/30/2015)... , March 30, 2015  Caris Life Sciences® today ... targeting specific pathways may have potentially significant benefit in ... study results were highlighted today in an oral presentation ... Oncology (SGO) 2015 Annual Meeting on Women,s Cancer in ... study is one of four presented at the annual ...
(Date:3/30/2015)... March 30, 2015  Cochlear Corporation Vice President ... leave Cochlear to join Valencia Technologies ( www.valenciatechnologies.com ... Jeff Greiner , who is the CEO of ... Development and will be responsible for generating enthusiasm ... Valencia,s coin-sized neuromodulation device in the ...
Breaking Medicine Technology:Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 3Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 4Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 5Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 6Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 7Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 2Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 3Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 4Cochlear VP of U.S. Sales Jerry Schloffman Accepts Chief of Market Development Position at Valencia Technologies 2
... Aug. 17 Cardica, Inc. (Nasdaq: CRDC ) ... year ended June 30, 2010. Cardica,s management will host a ... financial results and provide an update on the company,s business. ... efforts on the Microcutter family of products and we have ...
... 17 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Inc. (ZyStor), a privately-held biotechnology company developing enzyme replacement ...  ZyStor,s lead product candidate is ZC-701, a novel fusion ... in development for Pompe disease. Under the ...
Cached Medicine Technology:Cardica Announces Fiscal 2010 Fourth Quarter and Year End Financial Results 2Cardica Announces Fiscal 2010 Fourth Quarter and Year End Financial Results 3Cardica Announces Fiscal 2010 Fourth Quarter and Year End Financial Results 4Cardica Announces Fiscal 2010 Fourth Quarter and Year End Financial Results 5Cardica Announces Fiscal 2010 Fourth Quarter and Year End Financial Results 6BioMarin Acquires ZyStor Therapeutics, Inc. 2BioMarin Acquires ZyStor Therapeutics, Inc. 3BioMarin Acquires ZyStor Therapeutics, Inc. 4BioMarin Acquires ZyStor Therapeutics, Inc. 5
(Date:3/31/2015)... Homeowners and landscapers in the Jacksonville, ... in action and installed in a parking lot. ... display plot of Drivable Grass at their new outlet ... a permeable concrete pavement system designed for grass plantings. ... pavement, Drivable Grass qualifies for several LEED credits. LEED, ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 First ... freestanding emergency rooms in the United States, announced that ... , “I am pleased to announce that we ... metroplex in Haslet,” said Dr. James M. Muzzarelli, Executive ... First Choice Emergency Room is revolutionizing the delivery of ...
(Date:3/31/2015)... Dr. Hendler’s Vitamin Mints is a ground ... a recent debut on Food Fortunes , Food Network’s ... Company embraces Gonzo style publicity and pulls out all the ... The Vitamin Mint -- created by the late Dr. ... (a.k.a. the bible of supplements) and other great works such ...
(Date:3/31/2015)... Oshkosh, Wisconsin (PRWEB) March 31, 2015 The ... July 5 to October 2 in North America, and dates ... local areas. The group will perform many great hits during ... scheduled for March 30 on Hollywood Boulevard that will air ... first television appearance in the U.S. featuring David Lee Roth. ...
(Date:3/30/2015)... Wireless Analytics, LLC , a ... announced as one of the Boston Business Journal’s ... companies in Massachusetts. The list represents 70 privately ... from 2011 through 2014. 2015 marks the second ... recognized Wireless Analytics’s revenue growth. The Danvers-based managed ...
Breaking Medicine News(10 mins):Health News:Super-Sod Recently Completed a Drivable Grass Permeable Paver Demo at their Jacksonville Store 2Health News:First Choice Emergency Room to Open New Facility in Haslet, Texas 2Health News:What Do Mints, a World Renowned UCSD Biochemist, Vitamins and a Zany Musician Have in Common? 2Health News:Van Halen Presale Tickets: QueenBeeTickets.com Kicks Off Van Halen Ticket Sales with Reduced Prices on Seats for the 2015 Concert Tour During This Week's Presales 2Health News:Wireless Analytics Growth Streak Continues; Named to Boston Business Journal’s Pacesetters Second Year In a Row 2Health News:Wireless Analytics Growth Streak Continues; Named to Boston Business Journal’s Pacesetters Second Year In a Row 3
... , , SAN CLEMENTE, Calif., June 2 ... from among approximately 500 Direct Selling Association (DSA) member companies ... Rising Star award. STEMTech is responsible for bringing to market ... supplement, StemEnhance(R). , , According to STEMTech,s CEO, ...
... BOSTON In investigating the complex neurocircuitry behind weight gain ... plays a key role in the process. But within the ... exact pathways that the hormone travels to exert its influence ... investigators at Beth Israel Deaconess Medical Center (BIDMC) sheds further ...
... WASHINGTON, June 2 NASA has selected four proposals for ... in space. NASA selected proposals from the New York ... University of Texas Medical Branch in Houston, Loma ... in Washington. The universities will work with collaborating organizations around ...
... to computers, TV and more , TUESDAY, June 2 (HealthDay ... increases a child,s risk for numerous health issues, such as ... to a U.S. expert. , On average, American children and ... such as TV, computers, Internet, video games and VCR or ...
... seem like a disastrous scenario -- millions of people ... brushing past one another on crowded sidewalks. A ... a truly disastrous epidemic scenario could also take place ... Scoglio, associate professor of electrical and computer engineering, is ...
... (June 1, 2009) Cardiovascular disease (CVD), the leading ... issue contributing to 2,400 deaths each day. Periodontal disease, a ... support the teeth affects nearly 75 percent of Americans and ... prevalence rates of these disease states seem grim, research suggests ...
Cached Medicine News:Health News:Stem Cell Nutrition Company, STEMTech HealthSciences, Chosen as Finalist for Prestigious DSA Rising Star Award 2Health News:Study further expands understanding of leptin's role in brain neurocircuitry 2Health News:Study further expands understanding of leptin's role in brain neurocircuitry 3Health News:NASA Selects Four Proposals to Study Space Radiation Risks 2Health News:Too Much Media May Be Tough on Kids' Health 2Health News:Computer modeling shows strategies to rein in epidemics need to be retooled for rural populations 2Health News:Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 2Health News:Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 3
Lytec Medical 2004 practice management software is designed to help you more effectively manage your accounts receivable as well as track authorizations and inventory. Lytec Medical XE provides outst...
PremierEdge™ Stab Knives - 30°....
DCR Set, Angled....
... The Leica CM3050 S ... comfort with excellent safety standards ... cryosectioning applications. The Leica CM3050 ... choice for all cryosectioning research ...
Medicine Products: